12.12.2023 07:00:11
|
Changes to the Board of Directors of Baloise Holding Ltd
Baloise Holding AG
/ Key word(s): Personnel
Basel, 12 December 2023. The 2024 Annual General Meeting of Baloise Holding Ltd will see some changes to the membership of the company’s Board of Directors. Hugo Lasat will not stand for re-election after eight years as a member. The Board of Directors will propose Guido Fürer for election at the next Annual General Meeting. “On behalf of the Board of Directors, I would like to express my deep gratitude to Hugo Lasat for his invaluable work on the Board of Directors. During his time as a member of the Board of Directors of Baloise, Hugo Lasat made a crucial contribution to moving the Company forward. The Investment and Risk Committee, in particular, benefited from his extensive asset management expertise. Hugo Lasat will now focus solely on his work as the Group CEO of a Belgian asset management and banking group. We wish him all the best for the future,” says Dr Thomas von Planta, Chairman of the Board of Directors. The Board of Directors will propose Guido Fürer for election to the Board of Directors at the Annual General Meeting on 26 April 2024. Mr Fürer will add his considerable experience in the insurance industry and in asset management to the Board of Directors. After finishing his Master in Economics, Mr Fürer completed a doctorate in financial risk management at the University of Zurich. He also has an Executive MBA from INSEAD, Fontainebleau, France. He joined Swiss Re in 1997, where he held several positions. Following his appointment as Group Chief Investment Officer and member of the Group Executive Committee in 2012, he headed up Group Asset Management until the end of March 2023. Additionally, from 2019 to 2022, he was responsible for Swiss Re in Switzerland as Country President, and was Chairman of the Group Strategic Council. “We are delighted to have found a proven investment expert in Guido Fürer, whose extensive knowledge of the insurance industry will complement the expertise on the Board of Directors of Baloise,” says Thomas von Planta. The nomination is subject to the approval of the Annual General Meeting of Baloise Holding Ltd and the supervisory authority. Contact About Baloise
End of Media Release |
Language: | English |
Company: | Baloise Holding AG |
Aeschengraben 21 | |
4002 Basel | |
Switzerland | |
Phone: | +41 61 285 85 85 |
Fax: | +41 61 285 70 70 |
E-mail: | media.relations@baloise.com |
Internet: | https://www.baloise.com |
ISIN: | CH0012410517 |
Listed: | BX Berne eXchange; SIX Swiss Exchange |
EQS News ID: | 1794571 |
End of News | EQS News Service |
|
1794571 12.12.2023 CET/CEST
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Baloise AG (N) (Baloise Holding)mehr Nachrichten
09.12.24 |
SPI-Papier Baloise-Aktie: So viel Gewinn hätte ein Investment in Baloise von vor 3 Jahren eingefahren (finanzen.at) | |
09.12.24 |
Veränderungen im Verwaltungsrat der Baloise Holding AG (EQS Group) | |
09.12.24 |
Changes to the Board of Directors of Baloise Holding Ltd (EQS Group) | |
02.12.24 |
SPI-Titel Baloise-Aktie: So viel hätten Anleger an einem Baloise-Investment von vor einem Jahr verdient (finanzen.at) | |
27.11.24 |
Reisen, Familie und finanzielle Sicherheit: Die Top-Lebensziele der Schweizer Bevölkerung (EQS Group) | |
27.11.24 |
Travel, family and financial security: the top life goals of the Swiss (EQS Group) | |
26.11.24 |
Charles Ischi AG gewinnt den InnoPrix SO! 2024 für zukunftweisendes Pharmaprüfgerät (EQS Group) | |
26.11.24 |
Charles Ischi AG wins the 2024 InnoPrix SO! award for its innovative pharmaceutical tester (EQS Group) |